Physician

Ashok R Penmatcha, M.D.

According to 2025 Medicare claims, Ashok Penmatcha, M.D. (NPI: 1174595516) practices ophthalmology in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Scott, IA. This provider's primary affiliated billing organization is DAVENPORT EYE GROUP PC (NPI: 1508838954; TIN: 420982314) and primary practice location at 52803-2400. Penmatcha is affiliated with the Genesis Accountable Care Organization, LLC. (ACO ID: A4799), participating under the MSSP model.

Penmatcha's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 921 traditional Medicare patients, billed 1,970 HCPCS/CPT codes, and received $145,420 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 2,821 prescription claims across 496 beneficiaries totaling $194,196 in drug costs, led by Restasis (Cyclosporine). DME data shows 27 claims. Open Payments data shows 16 records totaling $325. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,272	2,207	$180,544
2016	1,183	2,067	$170,594
2017	1,228	2,197	$185,158
2018	1,202	2,058	$168,548
2019	1,090	1,849	$153,797
2020	982	1,684	$129,151
2021	990	1,803	$144,028
2022	948	1,732	$132,559
2023	894	1,688	$122,301
2024	921	1,970	$145,420

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	363	1,823	$161,185
2016	375	1,976	$179,461
2017	355	1,789	$178,604
2018	365	1,821	$171,425
2019	371	1,882	$200,351
2020	341	1,715	$200,153
2021	399	2,151	$232,501
2022	418	2,203	$226,600
2023	426	2,385	$238,554
2024	496	2,821	$194,196

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	136	140	$6,687
2016	111	113	$5,224
2017	56	56	$3,348
2018	79	79	$4,168
2019	45	45	$3,188
2020	13	13	$689
2021	45	45	$2,648
2022	55	55	$3,284
2023	25	25	$2,047
2024	27	27	$2,217

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	347	355	$76
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	83	92	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	223	283	$57
92012	Established patient problem focused exam of visual system	226	230	$52
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	162	183	$36

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	33	2,160	$40,639
Combigan	Brimonidine Tartrate/Timolol	81	4,087	$35,743
Lumigan	Bimatoprost	18	1,421	$15,067
Xiidra	Lifitegrast	14	630	$14,700
Cyclosporine	Cyclosporine	13	960	$8,633

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2303	Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens	N	14	14	$1,493
V2020	Frames, purchases	N	13	13	$724

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$325	Bausch & Lomb Americas Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ashok R. Penmatcha, M.D.?

Tedicare shows public-source Medicare data for Ashok R. Penmatcha, M.D. (NPI 1174595516), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ashok R. Penmatcha, M.D. have ACO affiliation data?

Ashok R. Penmatcha, M.D. is shown with ACO affiliation data for Genesis Accountable Care Organization, LLC. (MSSP, ACO ID A4799).

What billing organization is linked to Ashok R. Penmatcha, M.D.?

Ashok R. Penmatcha, M.D. is linked to DAVENPORT EYE GROUP PC (billing NPI 1508838954) in the available physician profile data.

Does Ashok R. Penmatcha, M.D. have Open Payments data?

Ashok R. Penmatcha, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.